Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to 0.83.

  • Pharma's Equity Ratio rose 1674.02% to 0.83 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.83, marking a year-over-year increase of 1674.02%. This contributed to the annual value of 0.72 for FY2025, which is 211.93% down from last year.
  • According to the latest figures from Q3 2025, Pharma's Equity Ratio is 0.83, which was up 1674.02% from 0.77 recorded in Q2 2025.
  • Pharma's 5-year Equity Ratio high stood at 0.94 for Q4 2021, and its period low was 0.69 during Q4 2024.
  • Moreover, its 5-year median value for Equity Ratio was 0.85 (2023), whereas its average is 0.84.
  • As far as peak fluctuations go, Pharma's Equity Ratio crashed by 1670.34% in 2024, and later soared by 1674.02% in 2025.
  • Quarter analysis of 5 years shows Pharma's Equity Ratio stood at 0.94 in 2021, then dropped by 3.12% to 0.91 in 2022, then fell by 11.9% to 0.8 in 2023, then fell by 14.25% to 0.69 in 2024, then grew by 20.46% to 0.83 in 2025.
  • Its Equity Ratio was 0.83 in Q3 2025, compared to 0.77 in Q2 2025 and 0.72 in Q1 2025.